Summary:
Clinical Research Study to Evaluate the Efficacy, Safety, and Tolerability of an Investigational Medication in Adults with Moderate to Severe Binge Eating Disorder.
Qualified Participants Must:
Be between 18 and 55 years of age
Be experiencing symptoms of Binge Eating